'Mr. Coury [chairman of Mylan, makers of the EpiPen] replied that he was untroubled [by critics of 10x price-gouging price hikes]. He raised both his middle fingers and explained, using colorful language, that anyone criticizing Mylan, including its employees, ought to go copulate with themselves. Critics in Congress and on Wall Street, he said, should do the same. And regulators at the Food and Drug Administration? They, too, deserved a round of anatomically challenging self-fulfillment.'